Literature DB >> 22040568

Effect of human epididymis protein 4 gene silencing on the malignant phenotype in ovarian cancer.

Shu-Li Zou1, Xiao-Hong Chang, Xue Ye, Hong-Yan Cheng, Ye-Xia Cheng, Zhi-Jian Tang, Zu-Juan Zhang, Li Gao, Xin-Hua Chen, Heng Cui.   

Abstract

BACKGROUND: Human epididymis secretory protein 4 (HE4) has been proved to be a promising novel biomarker for the detection of epithelial ovarian carcinomas. Compared with CA125, HE4 assay demonstrated an improved ability to discriminate between pelvic mass with malignant and benign disease. Though it is well known that HE4 is overexpressed in ovarian cancer, however, the role of HE4 in the carcinogenesis and progression of ovarian cancer remains unkown.
METHODS: In this study, we explored the role of HE4 in the carcinogenesis and progression of ovarian cancer. We screened nine ovarian cancer cell lines for HE4 expression, and using RNA interference (RNAi), we silenced HE4 gene expression in CaoV3 and SKOV3.ip1 ovarian cancer cell lines. We assessed the effect of HE4 gene silencing on the transformed phenotype by examining the cell cycle, apoptosis, proliferation and transwell migration/invasion in vitro.
RESULTS: HE4 gene silencing induces G0/G1 arrest and blocks the progression from the G1 to S phase in CaoV3 and SKOV3.ip1 cells. HE4 knockdown also inhibited cell proliferation, migration and invasion in SKOV3.ip1 cells in vitro.
CONCLUSION: HE4 may be involved in the regulation of the cell cycle and promote ovarian cancer migration and invasion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22040568

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  9 in total

1.  Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients.

Authors:  Q-L Li; C-J Wang; P Qi; Y-X Zhang
Journal:  Clin Transl Oncol       Date:  2017-04-25       Impact factor: 3.405

2.  WAP four-disulfide core domain protein 2 gene(WFDC2) is a target of estrogen in ovarian cancer cells.

Authors:  Yao Chen; Suihai Wang; Tiancai Liu; Yingsong Wu; Ji-Liang Li; Ming Li
Journal:  J Ovarian Res       Date:  2016-02-29       Impact factor: 4.234

3.  HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases.

Authors:  Anita Chudecka-Głaz; Aneta Cymbaluk-Płoska; Janusz Menkiszak; Agnieszka Sompolska-Rzechuła; Elżbieta Byra; Izabella Rzepka-Górska
Journal:  J Ovarian Res       Date:  2014-02-14       Impact factor: 4.234

4.  Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer.

Authors:  Anita Monika Chudecka-Głaz; Aneta Alicja Cymbaluk-Płoska; Janusz Leszek Menkiszak; Agnieszka Monika Sompolska-Rzechuła; Aleksandra Izabela Tołoczko-Grabarek; Izabella Anna Rzepka-Górska
Journal:  J Ovarian Res       Date:  2014-06-10       Impact factor: 4.234

5.  WAP four-disulfide core domain protein 2 promotes metastasis of human ovarian cancer by regulation of metastasis-associated genes.

Authors:  Yao Chen; Liping Huang; Suihai Wang; Tiancai Liu; Yingsong Wu; Ji-Liang Li; Ming Li
Journal:  J Ovarian Res       Date:  2017-07-05       Impact factor: 4.234

6.  Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer.

Authors:  Yan-Xiu Guo; Kuang Hong Neoh; Xiao-Hong Chang; Yukun Sun; Hong-Yan Cheng; Xue Ye; Rui-Qiong Ma; Ray P S Han; Heng Cui
Journal:  Oncotarget       Date:  2018-01-04

Review 7.  Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer.

Authors:  Nicole E James; Clinton Chichester; Jennifer R Ribeiro
Journal:  Front Oncol       Date:  2018-04-24       Impact factor: 6.244

8.  Predicting Diagnostic Potential of Cathepsin in Epithelial Ovarian Cancer: A Design Validated by Computational, Biophysical and Electrochemical Data.

Authors:  Hemangi Ranade; Priya Paliwal; Anis Ahmad Chaudhary; Sakshi Piplani; Hassan Ahmed Rudayni; Mohammed Al-Zharani; Ravi Ranjan Niraj; Manali Datta
Journal:  Biomolecules       Date:  2021-12-30

9.  Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer.

Authors:  Jorge A Alegría-Baños; José C Jiménez-López; Arely Vergara-Castañeda; David F Cantú de León; Alejandro Mohar-Betancourt; Delia Pérez-Montiel; Gisela Sánchez-Domínguez; Mariana García-Villarejo; César Olivares-Pérez; Ángel Hernández-Constantino; Acitlalin González-Santiago; Miguel Clara-Altamirano; Liz Arela-Quispe; Diddier Prada-Ortega
Journal:  J Ovarian Res       Date:  2021-07-19       Impact factor: 4.234

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.